Penn invests in pill tech citing industry demand
The Wales-based contract manufacturing organisation (CMO) has installed a mini-pactor compaction roller made by Switzerland-based technology firm Gerteis.
Mark Dean-Netscher, Vice President of International Operations at Penn Pharma, said: “Our contained manufacturing facility is world class and additional investment in roller compaction capacity allows us to offer even more development and manufacturing solutions to our customers.”
He explained that the new tech was intended to meet growing drug industry demand for continuous granulation capacity, particularly in the product of high potency tablets.
Dean-Netscher also predicted cost savings for customers.
“This roller compactor can be used from 1kg development scale up to 100kg per hour at production scale, without the need for additional scale up work. This will significantly reduce our clients’ costs and allow products to be developed and delivered to market far quicker.”
The tech investment fits with the strategy outlined by Packaging Coordinators Inc (PCI) when it bought Penn in 2014.
At the time the private equity backed firm said the Welsh CMO added manufacturing capcity to its traditional packaging services and distribution operations.
